文献速递技术与安全PETCT

interim [18F]FDG PET/CT多模态深度学习预测弥漫大B细胞淋巴瘤原发治疗失败

Multimodal deep learning model on interim [18F]FDG PET/CT for predicting primary treatment failure in diffuse large B-cell lymphoma.
PubMed 文献 · Eur Radiol · 2022-08-27

本研究基于中期[18F]FDG PET/CT影像数据,构建多模态深度学习模型预测低危弥漫大B细胞淋巴瘤的原发治疗失败。在205例主要数据集和44例外部队列中,对比混合学习模型表现最佳,主要数据集准确率91.22%、AUC 0.926,外部验证准确率88.64%、AUC 0.925,显示良好泛化能力。

要点

  • 中期PET/CT多模态深度学习模型可预测DLBCL原发治疗失败,外部验证AUC达0.925。
  • 特征级融合策略(对比混合学习)优于其他融合方式,提升预测性能。
  • 模型预测能力超越人类阅片,有望指导个体化治疗。

核心结论

  • 基于中期[18F]FDG PET/CT的多模态深度学习模型能准确预测低危DLBCL的原发治疗失败,并具有良好的外部泛化能力。

研究设计与样本

  • 回顾性研究,主要数据集205例接受中期[18F]FDG PET/CT及一线标准治疗的DLBCL患者用于模型开发,外部数据集44例用于泛化评估。
  • 采用Conv-LSTM网络骨干,比较五种多模态融合策略(像素混合、独立通道、独立分支、定量加权、混合学习),并选出最佳模型通过对比训练目标优化。

诊断标准与关键数值

  • 对比混合学习模型在主要数据集准确率91.22%、AUC 0.926;外部数据集准确率88.64%、AUC 0.925。

临床应用与阅片要点

  • 中期PET/CT影像数据可用于构建深度学习模型辅助预测DLBCL原发治疗失败,阅片时可关注多模态融合特征。
  • 模型预测性能超过人类能力,提示可辅助个体化临床治疗决策。

局限性

  • 原文未明确报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: The prediction of primary treatment failure (PTF) is necessary for patients with diffuse large B-cell lymphoma (DLBCL) since it serves as a prominent means for improving front-line outcomes. Using interim 18F-fluoro-2-deoxyglucose ([18F]FDG) positron emission tomography/computed tomography (PET/CT) imaging data, we aimed to construct multimodal deep learning (MDL) models to predict possible PTF in low-risk DLBCL.

METHODS: Initially, 205 DLBCL patients undergoing interim [18F]FDG PET/CT scans and the front-line standard of care were included in the primary dataset for model development. Then, 44 other patients were included in the external dataset for generalization evaluation. Based on the powerful backbone of the Conv-LSTM network, we incorporated five different multimodal fusion strategies (pixel intermixing, separate channel, separate branch, quantitative weighting, and hybrid learning) to make full use of PET/CT features and built five corresponding MDL models. Moreover, we found the best model, that is, the hybrid learning model, and optimized it by integrating the contrastive training objective to further improve its prediction performance.

RESULTS: The final model with contrastive objective optimization, named the contrastive hybrid learning model, performed best, with an accuracy of 91.22% and an area under the receiver operating characteristic curve (AUC) of 0.926, in the primary dataset. In the external dataset, its accuracy and AUC remained at 88.64% and 0.925, respectively, indicating its good generalization ability.

CONCLUSIONS: The proposed model achieved good performance, validated the predictive value of interim PET/CT, and holds promise for directing individualized clinical treatment.

KEY POINTS: • The proposed multimodal models achieved accurate prediction of primary treatment failure in DLBCL patients. • Using an appropriate feature-level fusion strategy can make the same class close to each other regardless of the modal heterogeneity of the data source domain and positively impact the prediction performance. • Deep learning validated the predictive value of interim PET/CT in a way that exceeded human capabilities.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Yuan, Shi, Huang, et al. Multimodal deep learning model on interim [18F]FDG PET/CT for predicting primary treatment failure in diffuse large B-cell lymphoma. Eur Radiol. 2022. PMID: 36029345. doi:10.1007/s00330-022-09031-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。